Phio Pharmaceuticals Corp.

NasdaqCM:PHIO Stock Report

Market Cap: US$12.9m

Phio Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:PHIO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
31 Dec 25BuyUS$5,150Robert BittermanIndividual5,000US$1.03
23 Dec 25BuyUS$5,100Robert BittermanIndividual5,000US$1.02
21 Nov 25BuyUS$5,700Robert BittermanIndividual5,000US$1.14
18 Nov 25BuyUS$6,350Robert BittermanIndividual5,000US$1.27
10 Jun 25BuyUS$6,050Robert FerraraIndividual2,500US$2.42
10 Jun 25BuyUS$4,840Robert BittermanIndividual2,000US$2.42
09 Jun 25BuyUS$4,125Robert BittermanIndividual1,500US$2.75

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PHIO?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders69,1480.595%
Institutions1,257,20110.8%
General Public10,290,90188.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 142.1%.

Top Shareholders

Top 25 shareholders own 11.39% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.64%
Orca Capital GmbH
538,707US$598.0k0%9.21%
1.27%
Geode Capital Management, LLC
147,254US$163.5k59%no data
1.03%
Jane Street Group, LLC
119,189US$132.3k0%no data
0.69%
Vanguard Capital Management, LLC
79,853US$88.6k0%no data
0.43%
Nomura Investment Management Business Trust
50,000US$55.5k0%no data
0.39%
Cetera Investment Advisers LLC
45,000US$50.0k5.88%no data
0.36%
Robert Bitterman
41,421US$46.0k0%no data
0.33%
Vanguard Fiduciary Trust Company
38,169US$42.4k0%no data
0.3%
Hudson River Trading LLC
34,732US$38.6k0%no data
0.28%
Two Sigma Investments, LP
32,495US$36.1k124%no data
0.26%
Scientech Research LLC
30,032US$33.3k0%0.02%
0.23%
UBS Asset Management AG
26,987US$30.0k214%no data
0.21%
XTX Markets Limited
24,868US$27.6k0%no data
0.2%
Northern Trust Global Investments
23,758US$26.4k0%no data
0.17%
GSA Capital Partners LLP
19,864US$22.0k0%no data
0.13%
Robert Ferrara
15,666US$17.4k0%no data
0.13%
Two Sigma Securities, LLC
15,224US$16.9k0%no data
0.086%
CapFinancial Partners, LLC
10,000US$11.1k0%no data
0.072%
Patricia Bradford
8,351US$9.3k0%no data
0.066%
Tower Research Capital Europe Limited
7,620US$8.5k0%no data
0.052%
Morgan Stanley
6,000US$6.7k0%no data
0.02%
Curtis Lockshin
2,355US$2.6k0%no data
0.017%
Osaic Wealth, Inc.
2,000US$2.2k0%no data
0.017%
Spire Wealth Management, LLC
2,000US$2.2k0%no data
0.012%
Jonathan Freeman
1,355US$1.5k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/01 09:44
End of Day Share Price 2026/06/01 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Phio Pharmaceuticals Corp. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Maxim JacobsEdison Investment Research
Matthew KellerH.C. Wainwright & Co.
Alexander HantmanSidoti & Company, LLC